<!-- PageNumber="961" -->
<!-- PageHeader="BDNF Modulates GABA and Glycine in Lamina II" -->

nociceptors, can be released following high frequency
stimulation of nociceptive primary afferent fibers
(Lever et al., 2001), and plays an important role in
regulating inflammatory pain thresholds and secondary
hyperalgesia (Thompson et al., 1999; Zhao et al.,
2006). On the other hand exogenously applied BDNF
causes thermal analgesia and attenuates mechanical
allodynia (Siuciak et al., 1994; Cejas et al., 2000).

At the cellular level, the neurotrophin is able to
potentiate glutamatergic synaptic transmission be-
tween primary afferent fibers and dorsal horn neurons,
by modulating postsynaptic NMDA receptors
(Slack et al., 2004; Garraway et al., 2003). Recent
evidence has been provided that BDNF, acting on
trkB receptors, causes an increase of spontaneous glutamate
release in dorsal horn lamina II, both in control
animals and during inflammation (Bardoni et al.,
2004; Matayoshi et al., 2005).

Nonetheless, a modulatory action of BDNF on inhibitory
synaptic transmission in dorsal horn has also
been reported: BDNF released from microglia cells
causes a modulation of Cl-transporter expression in
lamina I neurons, and a shift of chloride equilibrium
potential to positive values (Coull et al., 2005). Moreover,
the application of BDNF to the isolated adult
rat spinal cord increases KCl-evoked GABA content
in the collected superfusate (Pezet et al., 2002).

The role of BDNF in regulating GABAergic and
glycinergic transmission in dorsal horn, however, has
not been fully investigated. Furthermore, although the
distribution of full length (fl) functional trkB receptors
has recently been investigated in rat and mouse lamina
II (Salio et al., 2005), the presence of these receptors
on inhibitory interneurons in dorsal horn has not been
reported yet. In this study, we tested the hypothesis
that BDNF can control the release of GABA and glycine
in superficial dorsal horn. Since local GABAergic
and glycinergic inhibition is critical for gating of nociceptive
transmission (Malcangio and Bowery, 1996),
any effect of BDNF on inhibitory synapses could have
a great impact on pain signaling, especially in pathological
conditions of persistent pain. By using the
patch-clamp technique, we have studied the modulatory
effects of BDNF on spontaneous and evoked
release of GABA and glycine in lamina II neurons
from neonatal rats. Furthermore, by performing ultrastructural
immunocytochemical studies, we have
determined the pattern of expression of fl-trkB receptors
at GABAergic synapses in this lamina.


# METHODS


## Animals

Experiments were carried out in Sprague-Dawley postnatal
rats, ranging in age from 8 (P8) to 30 days (P30). Patch-
clamp experiments were carried out in P8-P16 animals,
whereas histology was performed in young-adult rats (P25-
P30). All experimental procedures were in strict accordance
with the Italian and EU regulation on animal welfare, and
previously authorized by the Italian Ministry of Health.


### Electrophysiological Recordings

Slice Preparation. Postnatal Sprague-Dawley rats were
anesthetized with halothane and decapitated, the spinal cord
and vertebrae were rapidly removed and placed in ice-cold
Krebs' solution (composition in mM: 125 NaCl, 2.5 KCl, 1.25
NaH2PO4, 26 NaHCO3, 25 glucose, 1 MgCl2, and 2 CaCl2, pH
7.4, 320 mOsm), bubbled with carboxygen (95% O2, 5%
CO2). The lumbar part of the spinal cord was isolated, laid
down on an agarose block, and transverse slices (500 um thick)
were obtained using a vibrating microtome (Campden Instruments, UK). Slices were incubated in oxygenated Krebs' solution
at 35℃ for 1 h and used for recording within 6-7 h.

Patch-Clamp Recording and Focal Synaptic Stimulation. Patch-clamp recording in whole-cell configuration was
performed on visually identified lamina II neurons at room
temperature. Neurons were visualized by using a Zeiss Axiokop
microscope, fitted with Nomarski optics and connected
to a camera (Dage-MTI, USA). Slices were perfused at 1-
2 mL/min. Thick-walled borosilicate pipettes, having a resistance
of 3-5 mΩ, were filled with a solution having the following
composition (in mM): 130 Cs-gluconate, 10 CsCl, 11
EGTA, 1 CaCl2, 10 HEPES, and 2 Mg2+ -ATP, pH adjusted
to 7.2 with NaOH, osmolarity adjusted to 305 with sucrose.
Junction potential was corrected after recording.

Data were recorded and acquired using a Multiclamp
700A amplifier and pClamp 9 software (Molecular Devices,
USA). Sampling rate was 10 kHz, and data were filtered at
2 kHz. Both miniature inhibitory postsynaptic currents
(mIPSCs) and evoked inhibitory postsynaptic currents (eIPSCs)
were recorded in Krebs' solution, in constant presence of
10 μM NBQX and 50 μM D-APV; only for mIPSCs recording,
0.5 μM tetrodotoxin (TTX) was added to the bath solution.

Evoked IPSCs were obtained by focally stimulating the
tissue around the recorded cell with a patch-clamp pipette,
filled with Krebs' solution. The second pole was represented
by a silver wire placed close to the slice. Stimuli had
intensities of 0.1-1 mA and duration of 0.05-0.1 ms.
Evoked IPSCs with constant latency and no failures during
1 Hz stimulation were considered monosynaptic and tested
for BDNF.

Data Analysis and Statistics. Miniature IPSC amplitudes,
frequencies, and kinetics were determined using MiniAnalysis
software (Synaptosoft, Decatur, USA). Detection threshold
for mIPSCs was set at 8-10 pA. Selection of mIPSCs
was performed manually and events with rise-time higher
than 3 ms were usually discarded (the exclusion of slower
events did not affect the results of the analysis). Analysis of
mIPSCs was performed on the same time window (10 min)
during control and when the BDNF effect was stabilized.

<!-- PageFooter="Developmental Neurobiology. DOI 10.1002/dneu" -->